KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2025)

Aquestive Therapeutics has reported Asset Utilization Ratio over the past 8 years, most recently at 0.27 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.27 for Q4 2025, down 49.51% from a year ago — trailing twelve months through Dec 2025 was 0.27 (down 49.51% YoY), and the annual figure for FY2025 was 0.34, down 53.06%.
  • Asset Utilization Ratio for Q4 2025 was 0.27 at Aquestive Therapeutics, down from 0.34 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for AQST hit a ceiling of 0.87 in Q4 2023 and a floor of 0.27 in Q4 2025.
  • Median Asset Utilization Ratio over the past 5 years was 0.54 (2024), compared with a mean of 0.58.
  • Biggest five-year swings in Asset Utilization Ratio: soared 131.58% in 2022 and later crashed 49.51% in 2025.
  • Aquestive Therapeutics' Asset Utilization Ratio stood at 0.54 in 2021, then surged by 44.24% to 0.78 in 2022, then increased by 11.14% to 0.87 in 2023, then plummeted by 37.09% to 0.54 in 2024, then crashed by 49.51% to 0.27 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.27 (Q4 2025), 0.34 (Q3 2025), and 0.45 (Q2 2025) per Business Quant data.